What is the appropriate vancomycin dosing regimen for a patient weighing 145 pounds (approximately 66 kg) with end‑stage renal disease on dialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Vancomycin Dosing for ESRD on Dialysis

For a 145-pound (66 kg) patient with ESRD on hemodialysis, administer a loading dose of 1,000 mg followed by maintenance doses of 500 mg given during the last hour of each dialysis session (typically 3 times weekly).

Dosing Algorithm

Loading Dose

  • 1,000 mg for patients <70 kg (this patient is 66 kg)
  • Administer during the last 60 minutes of the first dialysis session 1
  • This achieves an initial dose of approximately 15 mg/kg, which is the minimum recommended even in renal impairment 1

Maintenance Dosing

  • 500 mg administered during the last hour of each subsequent dialysis session
  • Given 3 times weekly with dialysis treatments 2
  • For functionally anephric patients (ESRD on dialysis), the dose required to maintain stable concentrations is 1.9 mg/kg/24 hours 1

Weight-Based Stratification

Recent evidence supports a more refined weight-based approach 3, 2:

  • 50-69 kg: 1,000 mg loading dose → 500 mg maintenance
  • 70-89 kg: 1,250-1,500 mg loading dose → 750 mg maintenance
  • 90-110 kg: 1,500-2,000 mg loading dose → 1,000 mg maintenance

Your patient at 66 kg falls into the first category.

Administration Specifics

  • Infuse during the last 60-90 minutes of dialysis to prevent vascular damage and preserve vascular access 4
  • Use high-flux dialysis if available
  • Infusion rate should not exceed 10 mg/min 1
  • Dilute each dose in at least 100 mL of compatible solution (200 mL for 1 gram doses) 1

Therapeutic Monitoring

Target Concentrations

  • Pre-dialysis trough: 15-20 mg/L for serious infections (bacteremia, endocarditis, osteomyelitis, pneumonia) 5
  • Pre-dialysis trough: ≥10 mg/L minimum to prevent resistance development 5
  • Target AUC24-48h/MIC ≥400 for optimal clinical outcomes in dialysis patients 6

Monitoring Schedule

  • Measure trough concentration before the second dialysis session (pre-dialysis level after loading dose) 6, 2
  • Pre-dialysis concentrations correlate strongly with AUC (R² = 0.921) and serve as a reliable surrogate 6
  • For serious infections, target pre-dialysis concentration/MIC ≥16.8 6
  • Continue monitoring before each dialysis session until stable therapeutic levels achieved

Critical Considerations

Common Pitfalls

  1. Underdosing: The standard 500 mg maintenance dose may be suboptimal in up to one-third of patients, particularly those >70 kg 2
  2. Timing errors: Administering vancomycin too early in dialysis results in excessive drug removal
  3. Dosing interval confusion: The 48-hour interval between dialysis sessions is standard, but 72-hour intervals (weekend gaps) require dose adjustment 7

Dosing Interval Adjustments

  • 48-hour intervals (weekday dialysis): Standard 500 mg maintenance dose
  • 72-hour intervals (weekend gap): Consider increasing maintenance dose to 750 mg to prevent subtherapeutic levels 7

Nephrotoxicity Monitoring

While the patient is already on dialysis, monitor for:

  • Concurrent nephrotoxic agents that increase risk 5
  • Cutaneous reactions (rare vasculitis can occur, particularly with renal impairment) 8
  • Thrombocytopenia and eosinophilia as early warning signs 8

Dose Adjustments Based on Levels

If pre-dialysis trough is:

  • <10 mg/L: Increase maintenance dose by 250 mg
  • 10-20 mg/L: Continue current regimen
  • >20 mg/L: Decrease maintenance dose by 250 mg or extend interval

The FDA label notes that for anuria, 1,000 mg every 7-10 days has been used historically 1, but this approach is outdated and does not achieve the aggressive targets needed for serious MRSA infections based on current guidelines 5.

This protocol achieves therapeutic pre-dialysis troughs of 10-20 mg/L in 76.9% of patients after the loading dose and 65.5-89.7% at steady state 2.

Related Questions

What is the appropriate vancomycin dosing regimen for a patient undergoing hemodialysis?
In a hemodialysis patient being treated with vancomycin (generic) for sepsis who missed today's dialysis, should I obtain a vancomycin trough level with tomorrow morning labs and postpone the 500 mg post‑dialysis dose until after the scheduled session?
What is the appropriate vancomycin dosing regimen?
What is the appropriate vancomycin dosing regimen for an adult with impaired renal function, including adjustments for intermittent hemodialysis and continuous renal replacement therapy?
What vancomycin dosing is appropriate for a patient on intermittent hemodialysis who is receiving 500 mg every 48 hours and has a trough level of 8.69 µg/mL?
What is the most likely diagnosis for a patient who developed tingling sensation 2 hours after a dive, with symptom onset 5 days ago?
What is the best way to treat a 44-year-old male with an oxidized LDL level of 69 mg/dL?
What is the lowest lithium dose and serum concentration that can effectively control mania?
What oral antidiabetic regimen should be started for a 44-year-old homeless Hmong male weighing 131.2 kg with newly diagnosed diabetes, admitted for right lower extremity cellulitis with maggots, leukocytosis, normal renal function, and heavy alcohol use?
What is the appropriate management for acute hypernatremia after ingesting a few grains of coarse salt?
What ceftriaxone dose should be given to a 2‑month‑old infant weighing 3.5 kg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.